SEC Form 4 · accession 0001213900-18-008317
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ellen O'Connor Vos
Director
Period of report
Jun 22, 2018
Accepted (ET)
Jun 27, 2018 · 12:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2018 | P | 400 | $10.35 | A | 9,734 | D | |
| Common Stock | Jun 22, 2018 | P | 50 | $10.29 | A | 9,784 | D | |
| Common Stock | Jun 25, 2018 | P | 1,100 | $10.47 | A | 10,884 | D | |
| Common Stock | Jun 25, 2018 | P | 250 | $10.72 | A | 11,134 | D |
Table II — derivative securities
No Table II lines on this filing.